In vitro simulation of the liver first-pass effect with biotransformation-competent HepG2 cells to study effects of MG-132 on liver and cancer cells.
- DOI
- 10.3233/ch-238108
- Published
- 2024
- Container
- Clinical hemorheology and microcirculation
- Publisher
- Not recorded
- Open access
- no
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3233/ch-238108,
title = {In vitro simulation of the liver first-pass effect with biotransformation-competent HepG2 cells to study effects of MG-132 on liver and cancer cells.},
author = {Kammerer S and Nowak E and Mantke R and Jung F and Küpper JH},
year = {2024},
journal = {Clinical hemorheology and microcirculation},
doi = {10.3233/ch-238108},
url = {https://doi.org/10.3233/ch-238108}
}RIS
TY - JOUR TI - In vitro simulation of the liver first-pass effect with biotransformation-competent HepG2 cells to study effects of MG-132 on liver and cancer cells. AU - Kammerer S AU - Nowak E AU - Mantke R AU - Jung F AU - Küpper JH PY - 2024 JO - Clinical hemorheology and microcirculation DO - 10.3233/ch-238108 UR - https://doi.org/10.3233/ch-238108 ER -
APA
S, K., E, N., R, M., F, J., & JH, K. (2024). In vitro simulation of the liver first-pass effect with biotransformation-competent HepG2 cells to study effects of MG-132 on liver and cancer cells.. Clinical hemorheology and microcirculation. https://doi.org/10.3233/ch-238108
Source records
- pubmed · retrieved 2026-09-25T01:17:30.981Z
- europe-pmc · retrieved 2026-09-25T01:17:31.000Z